NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
5.59
+0.34 (6.48%)
At close: Aug 6, 2026, 4:00 PM EDT
5.40
-0.19 (-3.40%)
Pre-market: Aug 7, 2026, 7:21 AM EDT
NextCure Employees
NextCure had 40 employees as of December 31, 2025. The number of employees decreased by 3 or -6.98% compared to the previous year.
Employees
40
Change (1Y)
-3
Growth (1Y)
-6.98%
Revenue / Employee
n/a
Profits / Employee
-$1,068,700
Market Cap
20.19M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 40 | -3 | -6.98% |
| Dec 31, 2024 | 43 | -39 | -47.56% |
| Dec 31, 2023 | 82 | -17 | -17.17% |
| Dec 31, 2022 | 99 | 12 | 13.79% |
| Dec 31, 2021 | 87 | -3 | -3.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Celularity | 115 |
| Daré Bioscience | 24 |
| Atossa Therapeutics | 16 |
| Werewolf Therapeutics | 14 |
| Cellectar Biosciences | 11 |
| Cocrystal Pharma | 10 |
| Neuphoria Therapeutics | 8 |
NXTC News
- 15 hours ago - NextCure reports Q2 EPS ($2.80), consensus ($1.92) - TheFly
- 15 hours ago - NextCure Quarterly report: Q2 2026 - Filings
- 15 hours ago - NextCure Earnings release: Q2 2026 - Filings
- 21 days ago - NextCure trading resumes - TheFly
- 21 days ago - NextCure trading halted, volatility trading pause - TheFly
- 23 days ago - Why Is Penny Stock NextCure (NXTC) Up Today? - TipRanks
- 24 days ago - NextCure, Avere Therapeutics enter definitive merger agreement - TheFly
- 24 days ago - NextCure, Avere Therapeutics enter definitive merger agreement - TheFly